These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19560881)

  • 1. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
    Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
    van Sörnsen de Koste JR; Senan S; Underberg RW; Oei SS; Elshove D; Slotman BJ; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):334-9. PubMed ID: 16168828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
    Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
    Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
    Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
    Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of internal target volume definition by limited four-dimensional computed tomography, the addition of patient-specific margins, or the addition of generic margins when planning radical radiotherapy for lymph node-positive non-small cell lung cancer.
    Hughes S; McClelland J; Chandler A; Adams M; Boutland J; Withers D; Ahmad S; Blackall J; Tarte S; Hawkes D; Landau D
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):293-300. PubMed ID: 18234482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProCaLung - Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium
    Charlier F; Descamps T; Lievens Y; Geets X; Remouchamps V; Lambrecht M; Moretti L
    Radiother Oncol; 2022 Feb; 167():57-64. PubMed ID: 34890738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.
    Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
    Videtic GM; Rice TW; Murthy S; Suh JH; Saxton JP; Adelstein DJ; Mekhail TM
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):702-6. PubMed ID: 18374513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified CT-based definition of the supraclavicular and infraclavicular nodal volumes in breast cancer.
    Atean I; Pointreau Y; Ouldamer L; Monghal C; Bougnoux A; Bera G; Barillot I
    Cancer Radiother; 2013 Feb; 17(1):39-43. PubMed ID: 23333457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Peer Review in Reducing Uncertainty in the Definition of the Lung Target Volume Among Trainee Oncologists.
    Mercieca S; Pan S; Belderbos J; Salem A; Tenant S; Aznar MC; Woolf D; Radhakrishna G; van Herk M
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):363-372. PubMed ID: 32033892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
    Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
    Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma.
    Piva C; Genovesi D; Filippi AR; Balducci M; Barra S; Buglione M; Busetto M; Ciammella P; Franzone P; De Sanctis V; Simontacchi G; Fusella M; Ricardi U;
    Pract Radiat Oncol; 2015; 5(6):383-9. PubMed ID: 26547826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
    Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
    J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
    Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
    J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.